JH

Jenny Holt

Chief Development Officer

Ray Therapeutics

Ray Therapeutics Pipeline

DrugIndicationPhase
RTx-015Retinitis PigmentosaPhase 1
RTx-021Stargardt’s DiseaseDiscovery